Ascentage Pharma Group International

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Ascentage Pharma Group International had 353.22M in cash and cash equivalents.

Ascentage Pharma Group International reported 381.01M in total liabilities as of the latest reported quarter, including 238.13M in current liabilities and 142.87M in non-current liabilities.

As of the latest reported quarter, Ascentage Pharma Group International's total assets were 574.34M, consisting of 426.62M in current assets and 147.72M in non-current assets.

Ascentage Pharma Group International reported 193.33M in total shareholders' equity as of the latest reported quarter.